SHP099

SHP099
Clinical data
Drug classSHP2 inhibitor
Identifiers
  • 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine
CAS Number
PubChem CID
ChemSpider
ChEMBL
PDB ligand
Chemical and physical data
FormulaC16H19Cl2N5
Molar mass352.26 g·mol−1
3D model (JSmol)
  • CC1(CCN(CC1)C2=CN=C(C(=N2)N)C3=C(C(=CC=C3)Cl)Cl)N
  • InChI=1S/C16H19Cl2N5/c1-16(20)5-7-23(8-6-16)12-9-21-14(15(19)22-12)10-3-2-4-11(17)13(10)18/h2-4,9H,5-8,20H2,1H3,(H2,19,22)
  • Key:YGUFCDOEKKVKJK-UHFFFAOYSA-N

SHP099 is a drug that acts as an inhibitor of the protein tyrosine phosphatase enzyme SHP-2 (PTPN11). It was developed as a potential agent for the treatment of cancer, but while it is potent, orally active and effective at inhibiting SHP-2 activity and slowing tumor growth, it was not developed for clinical use because of dose-limiting side effects. However it continues to be widely used in cancer research and a number of related derivatives have been developed.[1][2][3][4][5][6][7] It has also been used to research the role of SHP-2 in other processes such as regulation of bone growth during development.[8][9]

See also

References

  1. ^ Chen YN, LaMarche MJ, Chan HM, Fekkes P, Garcia-Fortanet J, Acker MG, et al. (July 2016). "Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases". Nature. 535 (7610): 148–152. Bibcode:2016Natur.535..148C. doi:10.1038/nature18621. PMID 27362227.
  2. ^ Garcia Fortanet J, Chen CH, Chen YN, Chen Z, Deng Z, Firestone B, et al. (September 2016). "Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor". Journal of Medicinal Chemistry. 59 (17): 7773–7782. doi:10.1021/acs.jmedchem.6b00680. OSTI 1404987. PMID 27347692.
  3. ^ Guo W, Xu Q (November 2020). "Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds". Journal of Pharmacological Sciences. 144 (3): 139–146. doi:10.1016/j.jphs.2020.06.002. PMID 32921395.
  4. ^ Wu J, Zhang H, Zhao G, Wang R (2021). "Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020)". Current Medicinal Chemistry. 28 (19): 3825–3842. doi:10.2174/1568011817666200928114851. PMID 32988341.
  5. ^ Petrocchi A, Ciammaichella A (May 2024). "A patent review of SHP2 allosteric inhibitors (2018-present)". Expert Opinion on Therapeutic Patents. 34 (5): 383–396. doi:10.1080/13543776.2024.2365410. PMID 38842843.
  6. ^ Marotta M, Zirpoli S, Prevete N, De Simone C, Di Cristofano A, Liotti F, et al. (September 2025). "SHP2 is a multifunctional target in anaplastic thyroid carcinoma: Cell intrinsic and immune-dependent anti-tumor effects". Biomedicine & Pharmacotherapy. 190 118384. doi:10.1016/j.biopha.2025.118384. PMID 40752423.
  7. ^ Jama M, Mosa FE, Overduin M, Barakat KH (2026). "Structural insights into the binding modes of SHP2 allosteric inhibitors". In Silico Pharmacology. 14 (1) 51. doi:10.1007/s40203-025-00551-x. PMC 12847482. PMID 41613633.
  8. ^ Jensen NR, Kelly RR, Kelly KD, Khoo SK, Sidles SJ, LaRue AC (April 2023). "From Stem to Sternum: The Role of Shp2 in the Skeleton". Calcified Tissue International. 112 (4): 403–421. doi:10.1007/s00223-022-01042-3. PMID 36422682.
  9. ^ Zhang Q, Li N, Dai ZZ, Liu XM, Ding J, Sha L, et al. (2025). "SHP2 inhibition by SHP099 attenuates IL-6-driven osteoclastogenesis in growth plate injury". Frontiers in Immunology. 16 1659230. doi:10.3389/fimmu.2025.1659230. PMC 12394037. PMID 40895539.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.